Identifying TF-miRNA-mRNA regulatory modules in nitidine chloride treated HCC xenograft of nude mice

Li Gao1, Dan-Dan Xiong1, Rong-Quan He2

  • 1Department of Pathology, First Affiliated Hospital of Guangxi Medical University Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Insights

Nitidine chloride (NC) shows tumor suppressive effects in hepatocellular carcinoma (HCC). This study elucidates NC's mechanism by analyzing miRNA and mRNA changes in HCC, identifying key regulatory networks and prognostic factors like IFIT2 and IFIT3.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Nitidine chloride (NC) exhibits tumor suppressive properties in various cancers, including hepatocellular carcinoma (HCC).
  • The precise pharmacological mechanism of NC in HCC remains largely unelucidated.
  • Understanding these mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the molecular mechanism of Nitidine chloride (NC) in hepatocellular carcinoma (HCC).
  • To identify differentially expressed miRNAs (DEmiRNAs) and mRNAs (DEmRNAs) regulated by NC in HCC.
  • To construct regulatory networks involving transcription factors (TFs), DEmiRNAs, and DEmRNAs in HCC.

Main Methods:

  • A subcutaneous tumor xenograft model using SMMC7721 HCC cell lines in nude mice was established.
  • MiRNA and mRNA sequencing were performed on xenograft tissues before and after NC treatment.
  • Bioinformatic analyses, including network construction and protein-protein interaction analysis, were utilized to identify hub genes and regulatory axes.

Main Results:

  • Five up-regulated miRNAs (e.g., hsa-miR-628-5p) and five down-regulated miRNAs (e.g., hsa-miR-378d) were identified.
  • Potential target genes of up-regulated miRNAs were associated with epithelial-to-mesenchymal transition.
  • Hub genes ITGA6 and ITGB4 were validated as up-regulated in HCC; IFIT2 and IFIT3 showed prognostic value.

Conclusions:

  • The study identified novel regulatory axes (NC-DEmiRNAs-DEmRNAs and TFs-DEmiRNAs-DEmRNAs) potentially underlying NC's mechanism in HCC.
  • Validated hub genes and prognostic factors provide insights into HCC pathogenesis and therapeutic targets.
  • This research contributes to understanding NC's role in HCC and suggests potential biomarkers for patient outcomes.

Related Concept Videos